Skip to content
Disclosery

EXANE DERIVATIVES: ETSY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ETSY, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 14 ETSY shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 14 shares
    Change vs previous 13F -729 shares

    <0.01% of the 13F portfolio, value $1,025.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 743 shares
    Change vs previous 13F -111 shares

    0.03% of the 13F portfolio, value $92,334.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 854 shares
    Change vs previous 13F -244 shares

    0.05% of the 13F portfolio, value $186,968.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,098 shares
    Change vs previous 13F -211 shares

    0.06% of the 13F portfolio, value $228,332.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,309 shares
    Change vs previous 13F +59 shares

    0.06% of the 13F portfolio, value $246,741.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,250 shares
    Change vs previous 13F -1,230 shares

    0.08% of the 13F portfolio, value $252,076.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,480 shares
    Change vs previous 13F +965 shares

    0.13% of the 13F portfolio, value $441,196.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,515 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $184,259.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).